Articles
Interviews and perspectives from senior medical affairs consultants on building field medical teams, European strategy, and what it takes to support clinical development from early phase through launch.
21 September 2026
From Zero to Systemic: Diagnosing an At-Risk Trial With No Prior Medical Affairs Footprint
A trial behind on enrollment, and no medical affairs footprint to build on. Why the first job is a consistent baseline at every site, and how that tells you whether you have one trial-level problem or eighty separate ones.
Read the article → 17 August 2026Building the Right Field Medical Team: A Conversation on Early-Stage Biotech Strategy
A 25-year field medical affairs veteran on why Europe gets left out of early planning, the risk of overbuilding before launch, and why a fractional model can move faster than permanent headcount.
Read the article →